Q-PAK THERAPEUTIC DRUG MONIT. CONTROL S— 510(k) K810078
Substantially EquivalentHyland Therapeutic Div., Travenol Laboratories
FDA 510(k) clearance K810078 for Q-PAK THERAPEUTIC DRUG MONIT. CONTROL S, Substantially Equivalent on 1981-02-02. Applicant: Hyland Therapeutic Div., Travenol Laboratories.
Clearance details
- Applicant
- Hyland Therapeutic Div., Travenol Laboratories
- Product code
- Code DIF
- Advisory panel
- Clinical Toxicology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Mchenry, IL, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.